<p>a. median (IQR) pVL up to 48 weeks after ART stop. b. predicted pVL over 4–48 weeks after ART stop, based on a representative participant (male infected through sex between men, aged 40 years and CD4 count 600 cells/mm<sup>3</sup> at ART stop; values in brackets are the 95% CI). CI = confidence intervals, IQR = interquartile range, pLV = plasma viral load.</p
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
<p><sup>†</sup>Patients with active HCV or HBV infection were excluded. Patients were on ART for a m...
*<p>Closest up to 24 weeks before ART stop. NB: 2 chronically-infected participants had CD4 count <3...
<p>a. median (IQR) pVL up to 48 weeks after ART stop. b. predicted pVL over 4–48 weeks after ART sto...
The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
OBJECTIVES: The magnitude of HIV viral rebound following ART cessation has consequences for clinical...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
OBJECTIVE:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in prim...
<div><p>Objective</p><p>A minority of HIV-1 positive individuals treated with antiretroviral therapy...
OBJECTIVE: To investigate the effect of a short course of HAART during primary HIV infection (PHI) o...
ObjectiveDespite evidence supporting antiretroviral therapy (ART) in recent HIV infection, little is...
OBJECTIVE: A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in pri...
Introduction: Data on patients with long-term exposure to ART is scarce because controlled studies u...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
<p><sup>†</sup>Patients with active HCV or HBV infection were excluded. Patients were on ART for a m...
*<p>Closest up to 24 weeks before ART stop. NB: 2 chronically-infected participants had CD4 count <3...
<p>a. median (IQR) pVL up to 48 weeks after ART stop. b. predicted pVL over 4–48 weeks after ART sto...
The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
OBJECTIVES: The magnitude of HIV viral rebound following ART cessation has consequences for clinical...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
OBJECTIVE:A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in prim...
<div><p>Objective</p><p>A minority of HIV-1 positive individuals treated with antiretroviral therapy...
OBJECTIVE: To investigate the effect of a short course of HAART during primary HIV infection (PHI) o...
ObjectiveDespite evidence supporting antiretroviral therapy (ART) in recent HIV infection, little is...
OBJECTIVE: A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in pri...
Introduction: Data on patients with long-term exposure to ART is scarce because controlled studies u...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
<p><sup>†</sup>Patients with active HCV or HBV infection were excluded. Patients were on ART for a m...
*<p>Closest up to 24 weeks before ART stop. NB: 2 chronically-infected participants had CD4 count <3...